News & Updates

Acupuncture for 8 weeks succeeds in lowering methadone dose and reducing cravings for opioid when compared with sham acupuncture, reports a study.

New drug applications approved by US FDA as of 1-15 July 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

A web-based cognitive behavioural self-help intervention demonstrates effectiveness in reducing eating disorder symptoms and illness-related burden in individuals with bulimia nervosa, according to a study.

Specific antipsychotic drugs such as high-dose quetiapine, high- and medium-dose clozapine, and high-dose olanzapine appear to be associated with a heightened risk of pneumonia among patients with schizophrenia, as shown in a study.

Individuals with type 2 diabetes mellitus (T2DM) who experience social isolation and loneliness may be at increased risk of diabetic microvascular complications (DMCs), as suggested in a study.

Gratitude is associated with increased longevity among older females, a population-based study has shown. 

Researchers from the Chinese University of Hong Kong (CUHK) have developed an artificial intelligence (AI)–powered app and actigraphy that effectively diagnoses depression by analyzing rest-activity, facial expression, mood, and voice.

A long-term healthcare plan appears necessary for people with psychotic disorders to detect and respond to changes in the trajectory of their disease course, suggests a study.